09/17/2014 - 10:09am

Misfit, makers of Shine, on Wednesday announced its second wearable product, Misfit Flash, a versatile and easy-to-use fitness and sleep monitor.

09/16/2014 - 1:59pm

Lupin has entered into a long-term partnership with Merck Serono for the implementation of the company's general medicines portfolio expansion initiative in emerging markets, helping to fulfill local needs for affordable medications.

09/16/2014 - 12:55pm

The Food and Drug Administration on Tuesday announced approval for Movantik (naloxegol), a treatment for opioid-induced constipation in adults.

09/16/2014 - 12:09pm

Baxter International announced that the Food and Drug Adminsitration approved Rixubis [coagulation factor IX (recombinant)] for the treatment, control and prevention of bleeding episodes, as well as perioperative management, in children with hemophilia B. 

09/15/2014 - 10:30am

Bayer HealthCare on Monday launched Aleve PM, the first over-the-counter nighttime product with a safe sleep aid plus the 12-hour pain-relieving strength of Aleve.

09/11/2014 - 1:21pm

The Food and Drug Administration approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as a chronic weight-management option. 

09/10/2014 - 10:38am

America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention.

09/10/2014 - 9:47am

RAP Protein Gummies brought a protein gummy product to market Wednesday. 

09/09/2014 - 11:54am

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.